• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; STYLET, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION SPECTRANETICS LEAD LOCKING DEVICE; STYLET, CATHETER Back to Search Results
Model Number 518-062
Device Problem Break (1069)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 03/24/2021
Event Type  Injury  
Manufacturer Narrative
Patient's date of birth unavailable.Patient's weight unavailable.(b)(4).
 
Event Description
A lead extraction procedure commenced to remove a right ventricular (rv) and a right atrial (ra) lead due to non function, and a redundant lead.Spectranetics lead locking devices (llds) were inserted into each lead to provide traction to aid in the leads'' extractions.The physician chose to use a spectranetics 14f glidelight laser sheath to begin the procedure.After progress stalled in the superior vena cava (svc) region, the physician chose to upsize to a 16f glidelight device, then used a spectranetics tightrail rotating dilator sheath.It was noted that the leads were heavily fibrosed.During use of the tightrail device, a small pericardial effusion appeared (please reference mdr 1721279-2021-00067, which captures the pericardial effusion that occurred while the tightrail device was in use).There was no surgical intervention required; the small effusion did not impact the patient's blood pressure.The physician attempted to unlock the llds from both the ra and rv leads, but was unsuccessful.Both leads, each containing an lld, were cut, capped and remained within the patient's body.The patient survived, and was successfully extubated the same day.This report is being submitted to capture the lld which was present within the rv lead and was cut and capped and remained in the patient's body.Please reference mdr 1721279-2021-00068 which captures the lld present within the ra lead which was cut and capped and remained in the patient's body.
 
Manufacturer Narrative
H3): a portion of the lld remained in the patient, and the remaining portion was discarded, thus no investigation could be completed.H6): added codes: 4727 and 4621.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRANETICS LEAD LOCKING DEVICE
Type of Device
STYLET, CATHETER
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
9965 federal drive
colorado springs CO 80921
MDR Report Key11701988
MDR Text Key255394271
Report Number1721279-2021-00069
Device Sequence Number1
Product Code DRB
UDI-Device Identifier00813132023072
UDI-Public(01)00813132023072(17)230125(10)FLP21A22
Combination Product (y/n)Y
PMA/PMN Number
K142116
Number of Events Reported123
Summary Report (Y/N)Y
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 03/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/25/2023
Device Model Number518-062
Device Catalogue Number518-062
Device Lot NumberFLP21A22A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BOSTON SCIENTIFIC 0185 RV ICD LEAD; BOSTON SCIENTIFIC 4135 RA PACING LEAD; SPECTRANETICS 14F GLIDELIGHT LASER SHEATH; SPECTRANETICS 16F GLIDELIGHT LASER SHEATH; SPECTRANETICS CVX-300 EXCIMER LASER SYSTEM; SPECTRANETICS LEAD LOCKING DEVICE; SPECTRANETICS TIGHTRAIL ROTATING DILATOR SHEATH
Patient Outcome(s) Other;
Patient Age47 YR
-
-